Cover Image
市場調查報告書

甲狀腺髓質癌:全球臨床實驗趨勢

Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 233618
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
甲狀腺髓質癌:全球臨床實驗趨勢 Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 109 Pages
簡介

本報告提供全球甲狀腺髓質癌治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 甲狀腺髓質癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上甲狀腺髓質癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上甲狀腺髓質癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

甲狀腺髓質癌治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca PLC
    • Exelixis, Inc.
    • Eisai
    • Sino Biopharmaceutical Limited
    • Sanofi
    • Immunomedics, Inc.
    • Globeimmune, Inc.
    • EANM Research Ltd.
    • Bayer AG
    • Amgen Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • University of Kentucky
    • University of Wisconsin Madison
    • Garden State Cancer Center
    • University of Texas M. D. Anderson Cancer Center
    • University of Southern California
    • Sidney Kimmel Comprehensive Cancer Center
    • University of Washington
    • Medical University of Vienna
    • Leiden University Medical Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2598CTIDB

GlobalData's clinical trial report, "Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Medullary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Medullary Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Medullary Thyroid Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Medullary Thyroid Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Medullary Thyroid Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Exelixis, Inc.
      • Clinical Trial Overview of Exelixis, Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Sino Biopharmaceutical Limited
      • Clinical Trial Overview of Sino Biopharmaceutical Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Immunomedics, Inc.
      • Clinical Trial Overview of Immunomedics, Inc.
      • Globeimmune, Inc.
      • Clinical Trial Overview of Globeimmune, Inc.
      • EANM Research Ltd.
      • Clinical Trial Overview of EANM Research Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
      • University of Wisconsin Madison
      • Clinical Trial Overview of University of Wisconsin Madison
      • Garden State Cancer Center
      • Clinical Trial Overview of Garden State Cancer Center
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • University of Southern California
      • Clinical Trial Overview of University of Southern California
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Medullary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sino Biopharmaceutical Limited, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Globeimmune, Inc., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EANM Research Ltd., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Garden State Cancer Center, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*

List of Figures

  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Medullary Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Medullary Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Medullary Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top